Alison R. Sehgal

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Alison R. Sehgal

Aug 5, 2024, 00:11 | Insight

5 year outcomes of SOC Axicabtagene Ciloleucel

Graham Collins, Associate Professor of Haematology and lymphoma specialist at Oxford Cancer and Haematology centre,…

Aug 4, 2024, 09:41 | Insight

Michael Jain: 5-year outcomes of standard-of-care Axicabtagene Ciloleucel in lymphoma patients

Michael Jain, Oncologist at Moffitt Cancer Center, shared on X: "What is important for long-term…

All: 2 Posts: 1 - 100

'

April is Head and Neck Cancer Awareness Month

'

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

'

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

'

Cancer Center Near Me: Dana-Farber Cancer Institute

'

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023